Thomas A. Fleisher - Concepedia

Author

Thomas A. Fleisher

Also Known As

Bradley E. Chipps, Chitra Dinakar, Gouni, Sushanth, Muraro, Antonella M, T A Fleisher, T Fleisher, T. Fleisher, T.A. Fleisher, THOMAS A. FLEISHER, Thomas A Fleisher

286

Publications

10.7K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institutes of Health Clinical Center National Institute of Allergy and Infectious Diseases National Cancer Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases

About

Thomas A. Fleisher is an author at National Institutes of Health specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	3.5K
2	Cell Biology	8	8	1.4K
3	Allergy	4	4	269
4	Health Sciences	2	2	48
5	Public Health	1	1	77

Thomas A. Fleisher

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
T Lymphocyte-Directed Gene Therapy for ADA <sup>−</sup> SCID: Initial Trial Results After 4 Years R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Science	1995	1.5K
Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy Crystal L. Mackall, Thomas A. Fleisher, Margaret R. Brown, New England Journal of Medicine	1995	1.1K
Immune dysregulation in human subjects with heterozygous germline mutations in <i>CTLA4</i> Hye Sun Kuehn, Weiming Ouyang, Bernice Lo, Science ImmunodeficienciesGeneticsImmunologyT-regulatory CellPathology	2014	823
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome Scott Canna, Adriana A. de Jesus, Sushanth Gouni, Nature Genetics InflammationImmune Cell DevelopmentMedicineImmunologyChronic Inflammation	2014	725
Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study Gabor G. Illei, Yuko Shirota, Cheryl Yarboro, Arthritis & Rheumatism	2010	501
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop João Bosco Oliveira, Jack Bleesing, Umberto Dianzani, Blood	2010	478
Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease Harry L. Malech, Phillip B. Maples, Narda Whiting‐Theobald, Proceedings of the National Academy of Sciences	1997	342
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy Elise M. N. Ferré, Stacey Rose, Sergio D. Rosenzweig, JCI Insight	2016	296
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade S Stojanov, Sivia Lapidus, Puja Chitkara, Proceedings of the National Academy of Sciences ImmunodeficienciesInnate Immune SystemImmunologyPathologyInnate Immunity	2011	283
Development of Antibodies to Fetal Calf Serum With Arthus-Like Reactions in Human Immunodeficiency Virus–Infected Patients Given Syngeneic Lymphocyte Infusions Thomas A. Selvaggi, Robert Walker, Thomas A. Fleisher Blood	1997	272

Page 1